Search all trials

Find therapies in clinical trials near you – page 17

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Small cell lung cancer extensive stage

Recruiting

Registered drugNo placebo

Phase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Siltuximab

Contact Research Centre

Non-small cell lung cancer metastatic

Recruiting

Registered drugNo placebo

Phase 2 Study of Imzokitug with drug combination as First‑Line Treatment for Adults with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC)

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bms-986340

Contact Research Centre

Tardive dyskinesia

Recruiting

Investigational

Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

Investigational

Bulgaria

Participants:18–64 years · 65+ years

Contact Research Centre

Dermatitis atopic

Recruiting

InvestigationalNo placebo

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Poland

Participants:0–17 years
Substances:Nemolizumab

Contact Research Centre

Type 2 diabetes mellitus

Recruiting

Registered drug

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Hereditary haemorrhagic telangiectasia

Recruiting

Investigational

A Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia

Investigational

Belgium

Participants:18–64 years · 65+ years

Contact Research Centre

Neoplasm

Recruiting

Registered drugNo placebo

Long‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Gastrooesophageal cancer+6

Recruiting

Registered drugNo placebo

Study of Rinatabart Sesutecan with glatiramer acetate in patients with advanced gastrointestinal cancers

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Glatiramer Acetate

Contact Research Centre

Idiopathic pulmonary fibrosis

Recruiting

Investigational

Efficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational

Austria

Participants:18–64 years · 65+ years

Contact Research Centre

Dermatitis atopic

Recruiting

Registered drug

Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Renal transplant

Recruiting

Registered drug

Safety of Two Doses of Siplizumab Compared with Rabbit Anti‑Human Thymocyte Immunoglobulin in Kidney Transplant Recipients Receiving Standard Immunosuppression

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Siplizumab

Contact Research Centre

Plasma cell myeloma refractory

Recruiting

Registered drug

Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma Patients Receiving JNJ-79635322 and Human Normal Immunoglobulin (IV)

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Tocilizumab

Contact Research Centre

Find therapies in clinical trials near you – page 17

10 282 trials match your criteria

Small cell lung cancer extensive stage

Phase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy

Non-small cell lung cancer metastatic

Phase 2 Study of Imzokitug with drug combination as First‑Line Treatment for Adults with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC)

Tardive dyskinesia

Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

Dermatitis atopic

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis

Type 2 diabetes mellitus

Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

Hereditary haemorrhagic telangiectasia

A Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia

Neoplasm

Long‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors

Gastrooesophageal cancer+6

Study of Rinatabart Sesutecan with glatiramer acetate in patients with advanced gastrointestinal cancers

Idiopathic pulmonary fibrosis

Efficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Dermatitis atopic

Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

Renal transplant

Safety of Two Doses of Siplizumab Compared with Rabbit Anti‑Human Thymocyte Immunoglobulin in Kidney Transplant Recipients Receiving Standard Immunosuppression

Plasma cell myeloma refractory

Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma Patients Receiving JNJ-79635322 and Human Normal Immunoglobulin (IV)

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.